Study: Does lumpectomy or mastectomy provide better survival for women with early stage breast cancer?

Printer Friendly Page

Read the article that we reviewed

Contents

At a glance In-depth
Findings     Limitations             
Questions for your doctor Resources  


STUDY AT A GLANCE

This study is about:

Whether survival is better for women with early-stage breast cancer who opted for breast-conserving surgery (surgery that only removes part of the breast, such as a lumpectomy) compared to women who had mastectomies.

Why is this study important?

Knowing the positives and negatives of the surgical options for women who are diagnosed with early-stage breast cancer is important. For example, research has shown that women who have mastectomy and reconstruction have many more complications than women who opt for lumpectomy and whole breast irradiation.  Also, the cost of breast-conserving surgery is usually less than the cost of mastectomy. But which surgery has better survival? That is one of the most important things to consider when deciding on a surgical treatment.

Study findings: 

  1. Women who had breast-conserving surgery had increased 10-year survival compared to women who got mastectomies. 

What does this mean for me?

While this data is interesting, it does not change care guidelines for women with early-stage breast cancer. Women should still decide what surgery they want based on their personal preference and all of the characteristics of their cancer. It is important to note that this study did not take into consideration whether or not the women had mutations in BRCA or other genes that are associated with an increased risk of a second breast cancer.

Posted 1/19/16

References

van Maaren M, et al. “Higher 10-year overall survival after breast-conserving therapy compared to mastectomy in early-stage breast cancer: A population-based study with 37,207 patients.” Presented December 2015 at the San Antonio Breast Cancer Symposium. 

Disclosure

FORCE receives funding from industry sponsors, including companies that manufacture cancer drugs, tests and devices. All XRAYS articles are written independently of any sponsor and are reviewed by members of our Scientific Advisory Board prior to publication to assure scientific integrity.

This article is relevant for:

Women with early stage breast cancer

This article is also relevant for:

Triple negative breast cancer

ER/PR +

Her2+ breast cancer

Breast cancer survivors

Women under 45

Women over 45

Be part of XRAY:

Expert Guidelines

The American Society of Breast Surgeons (ASBrS) developed practice guidelines for lumpectomy and mastectomy.

ASBrS recommendations for lumpectomy:

  • Current indications for BCS are:
    • A biopsy-proven diagnosis of DCIS or invasive breast cancer clinically assessed as resectable with clear margins and with an acceptable cosmetic result.
  • Current contraindications for BCS include:
    • Early pregnancy
    • Multicentric tumor involving 2 or more quadrants of the breast
    • Diffuse malignant/indeterminate microcalcifications
    • Inflammatory breast cancer
    • Persistently positive margins of excision 

ASBRrS recommendations for mastectomy:

  • Current indications for mastectomy are as follows:
    • Any cancer unsuitable for breast conservation, based on
      • Large tumor-to-breast-size ratio
      • Multicentric tumor
      • Insufficient response to neoadjuvant chemotherapy or endocrine therapy  
      • Persistently positive margins of excision
      • Inflammatory breast cancer
      • Extensive malignant/indeterminate microcalcifications
      • Early pregnancy
      • Proven or suspected inherited gene mutation 
      • Local recurrence following breast conserving surgery and radiation therapy 
      • Patients with a contraindication to radiation 
    • For risk-reduction in high-risk patients
      • Proven or suspected inherited gene mutation 
    • History of prior mantle radiation  

Updated: 01/10/2022

Questions to Ask Your Doctor

  • How do I decide which surgery is right for me?
  • I have been diagnosed with breast cancer before age 50, should I consider genetic testing before deciding on mastectomy or lumpectomy?
Peer Support

The following organizations offer peer support services for people with, or at high risk for breast cancer:

Updated: 01/08/2022

Who covered this study?

TIME

With early breast cancer treatment, less may be more: studies This article rates 4.5 out of 5 stars

Health Day

Lumpectomy plus radiation may beat mastectomy for early breast cancer This article rates 4.5 out of 5 stars

General Surgery News

More evidence supports breast conservation over mastectomy This article rates 4.0 out of 5 stars

Medscape

Ten-year data: Lumpectomy and radiotherapy trump mastectomy This article rates 3.5 out of 5 stars

How we rated the media

IN DEPTH REVIEW OF RESEARCH

Study background:

Research from the 1980s showed that survival is the same after breast-conserving surgery with radiation therapy or mastectomy.  Current studies show that survival may be better for women who have breast-conserving surgery with radiation therapy.

In December 2015, Dr. Marissa van Maaren from the Netherlands Comprehensive Cancer Organization presented “Higher 10-year overall survival after breast conserving therapy compared to mastectomy in early stage breast cancer: A population-based study with 37,207 patients” at the San Antonio Breast Cancer Symposium. This study by Dr. van Maaren and her colleagues looked at the differences in survival between breast-conserving surgery and mastectomy.

Researchers of this study wanted to know:

What is the difference in 10-year overall and distant metastasis-free survival after breast-conserving surgery compared to mastectomy for women with early-stage breast cancer?

Population(s) looked at in the study:

This study used information about 37,207 women from the Netherlands Cancer Registry. Researchers selected women with a first primary breast cancer tumor (up to five centimeters, with no more than three positive lymph nodes) diagnosed between 2000 and 2004. About 58% of the women were treated with breast-conserving surgery and radiation therapy; the remainder had mastectomy without radiation. While all of the data from the women were used for the overall survival data analysis, only data from women who were diagnosed in 2003 was used for the distant metastasis-free survival data analysis.

Study findings:                                                              

  1. Women who had breast-conserving surgery had approximately 20% increased overall survival compared to women who had mastectomy.
  2. Women with small tumors that had not spread to the lymph nodes, and had breast-conserving surgery had a better 10-year distant metastasis-free survival rate than those who had mastectomy.

Limitations:

The researchers noted that overall, patients in the breast-conserving surgery group were younger and had more favorable prognoses, which may have influenced the study outcome. A bigger issue is that the breast-conserving surgery patients also had radiation therapy, while the mastectomy patients did not, so whether or not the increased survival rate was directly due to radiation therapy in the breast-conserving therapy group cannot be conclusively stated. Also, it is important to note that the BRCA mutation status of the women was not reported, so we do not know if BRCA carriers who had a higher risk of a second cancer opted for mastectomy.

Guidelines:

 

Conclusions:

While this study supports previous data that says that overall survival is at least the same, if not better, with breast-conserving surgery, not enough conclusive proof exists to change guidelines. A larger prospective trial would be needed to determine which surgery provides better survival. Some patients may benefit much more from mastectomies than others, and some may benefit more from breast-conserving surgery. More work needs to be done to tease out these results. 

Posted 01/19/16

Back to XRAY Home